Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Hormones and the Endocrine System >  Pancreatic hormone and blood sugar regulation >  insulin glargine

insulin glargine

Basic information Safety Supplier Related

insulin glargine Basic information

Product Name:
insulin glargine
Synonyms:
  • insulin glargine
  • Insulin Glargine EP/USP
  • A21-Gly-B31-Arg-B32-Arg-insulin
  • Insulin, glycyl(A21)-arginyl(B31,B32)-
  • Lantus
  • Solostar
  • Solostar [insulin delivery pen]
  • Unii-2zm8cx04rz
CAS:
160337-95-1
MF:
C267H404N72O78S6
MW:
6062.89026
Mol File:
160337-95-1.mol
More
Less

insulin glargine Chemical Properties

storage temp. 
-20°C, Inert atmosphere
solubility 
Aqueous Acid (Very Slightly)
form 
Liquid
color 
White to Off-White
Sequence
A-chain: Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ile-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Tyr-Cys-Gly; B-chain: Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thr-Arg-Arg (Disulfide bridge: CysA6-CysA11, CysA7-CysB7, CysA20-CysB19)
CAS DataBase Reference
160337-95-1
More
Less

Safety Information

HS Code 
2937120000
More
Less

insulin glargine Usage And Synthesis

Uses

long-acting basal insulin analogue, helping control the blood sugar level of those with type 1 and type 2 diabetes mellitus. It is an analogue of human insulin made by replacing the asparagine residue at position A21 of the A-chain with glycine and adding

Uses

Insulin Glargine (>90%) is an insulin analogue used in the treatment of adults with type 1 or type 2 diabetes.

brand name

Lantus (Hoechst Marion Roussel).

Biological Activity

Insulin glargine is an approved long-acting insulin analog used for management of Diabetes Type 1 and Type 2. Insulin glargine is a human insulin analog where A-chain asparagine 21 was replaced by glycine and B-chain carboxy terminal was extended by two arginine residues.

in vivo

Insulin glargine (2-12.5 IU/kg; subcutaneous injection; 3-12 months) does not present a carcinogenic risk in rodents[2].
Insulin glargine (450 mg/kg; subcutaneous injection; 6 months) has an improving effect in a mouse model of diabetes[3].

Animal Model:Seven-week-old male db/db mice[3]
Dosage:450 mg/kg
Administration:Subcutaneous injection (s.c.); 6 months
Result:Significantly improved glucose tolerance.
Upregulated pancreatic β-cell functional genes, such as INS1, Pdx1, Pax4 and Pax6.

insulin glargineSupplier

Shanghai Yingxin Laboratory Equipment Co., Ltd. Gold
Tel
021-59178156 17002132182
Email
3146474380@qq.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com
Beijing HuaMeiHuLiBiological Chemical
Tel
010-56205725
Email
waley188@sohu.com
China Nobel Chem Co., Limited
Tel
+86(0)21 60484900
Wuxi Zhongkun Biochemical Technology Co., Ltd.
Tel
0510-85629785 18013409632
Email
sales@reading-chemicals.com